Enzyme Linked Immunosorbent Assay for the Quantitative Determination of Breast Cancer Antigen in Human Serum
- UID
- MFG/IVD/2020/000043_c64552978a14b90c26e4c3b5a4ffc509_6273317755c6f4d558c08be03fc9aa74
- Device class
- Class C
- Brand name
- CA 15-3
- Approving authority
- Sub Zonal Goa
- Product information
- QUALISA CA 15-3 is a Enzyme Linked Immunosorbent assay for the Quantitative Determination of Breast Cancer Antigen (CA 15-3) in Human Serum
Enzyme Linked Immunosorbent Assay for the Quantitative Determination of Breast Cancer Antigen in Human Serum is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID MFG/IVD/2020/000043_c64552978a14b90c26e4c3b5a4ffc509_6273317755c6f4d558c08be03fc9aa74. This device is marketed under the brand name CA 15-3. The license holder is ZEPHYR BIOMEDICALS A DIVISION OF TULIP DIAGNOSTICS PRIVATE LIMITED, and it is classified as Device Class Class C. The approving authority is Sub Zonal Goa.
This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.